Atossa to Present at the Sidoti Small-Cap Investor Conference
June 05 2024 - 8:30AM
Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the
“Company”), today announced that the Company will present at the
Sidoti Small-Cap Investor Conference being held June 12-13, 2024.
The presentation by Steven Quay, M.D., Ph.D., Atossa’s President
and Chief Executive Officer, will take place on Thursday, June 13
at 9:15 am eastern time. Atossa is a clinical stage
biopharmaceutical company developing innovative medicines in areas
of significant unmet medical need in oncology with a focus on
breast cancer.
To register and view a live webcast of the presentation, please
visit the event's website at:
https://sidoti.zoom.us/webinar/register/WN_MB9PZN5rTjeg5vMpcE82Gg
Following the conference, a recording of the webcast will be
made available on the investor relations page of Atossa’s website:
https://investors.atossatherapeutics.com/
About Atossa TherapeuticsAtossa Therapeutics,
Inc. is a clinical-stage biopharmaceutical company developing
innovative medicines in areas of significant unmet medical need in
oncology with a focus on using (Z)-endoxifen to prevent and treat
breast cancer. For more information, please visit
www.atossatherapeutics.com.
Contact:Eric Van ZantenVP, Investor and Public
Relations610-529-6219eric.vanzanten@atossainc.com
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From May 2024 to Jun 2024
Atossa Therapeutics (NASDAQ:ATOS)
Historical Stock Chart
From Jun 2023 to Jun 2024